Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
NORETHINDRONE ACETATE (UNII: 9S44LIC7OJ) (NORETHINDRONE - UNII:T18F433X4S), ETHINYL ESTRADIOL (UNII: 423D2T571U) (ETHINYL ESTRADIOL - UNII:423D2T571U)
Glenmark Pharmaceuticals Inc., USA
NORETHINDRONE ACETATE
NORETHINDRONE ACETATE 1 mg
ORAL
PRESCRIPTION DRUG
Norethindrone acetate and ethinyl estradiol tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD % Of Women Experiencing an Unintended Pregnancy in the First Year of Continuous Use Method Lowest Expected* Typical** (No contraception) (85) (85) Oral contraceptives 3 combined 0.1 N/A*** progestin only 0.5 N/A*** Diaphragm with spermicidal cream or jelly 6 20 Spermicides alone (foam, creams, gels, vaginal suppositories, and vaginal film) 6 26 Vaginal Sponge nulliparous 9 2
Norethindrone Acetate and Ethinyl Estradiol Tablets, USP are available in dispensers each containing 21 white to off-white tablets. Each tablet contains 1 mg of norethindrone acetate, USP and 0.02 mg of ethinyl estradiol, USP. The tablets are white to off-white, uncoated, round, flat-faced beveled-edge, debossed with ‘16’ on one side and ‘G’ on other side. NDC 68462-132-81 1 Carton of 3 Blisters Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Keep out of the reach of children. Protect from moisture.
Abbreviated New Drug Application
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL- NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLET GLENMARK PHARMACEUTICALS INC., USA ---------- NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS, USP 1 MG/ 0.02 MG RX ONLY WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including norethindrone acetate and ethinyl estradiol tablets, are contraindicated in women who are over 35 years of age and smoke (see CONTRAINDICATIONS and WARNINGS). DESCRIPTION Norethindrone Acetate and Ethinyl Estradiol Tablets, USP are progestogen-estrogen combinations. Each white to off-white tablet contains norethindrone acetate, USP (19-Norpregn-4-en- 20-yn-3-one,17-(acetyloxy)-, (17α), 1 mg; ethinyl estradiol 19-Norpregna-1,3,5(10)- triene-20-yne-3,17-diol, (17 α), 20 mcg. Also contains acacia, lactose monohydrate, magnesium stearate, corn starch, sucrose and talc. The structural formulas are as follows: CLINICAL PHARMACOLOGY Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which reduce the likelihood of implantation). PHARMACOKINETICS The pharmacokinetics of norethindrone acetate and ethinyl estradiol tablets have not been characterized; however, the following pharmacokinetic information regarding norethindrone acetate and ethinyl estradiol is taken from the literature. ABSORPTION Norethindrone acetate appears to be completely and rapidly deacetylated to norethindrone after oral administration, since the disposition of norethindrone acetate is indistinguishable from that of orally administered norethindrone (1). Norethindrone acetate and ethin Lugege kogu dokumenti